A decision framework for treating chronic immune thrombocytopenia with thrombopoietin receptor agonists

In this article, the authors assess the cost of treating chronic immune thrombocytopenia. This research article, from the Journal of Comparative Effectiveness Research, is free to access exclusively for The Evidence Base® members. Chronic immune thrombocytopenia (cITP) is a debilitating condition in which patients experience a range of bleeding-related symptoms from mild bruising to potentially fatal intracranial hemorrhage. In part due to their high risk of serious bleeding, patients’ quality of life is diminished. Bleeding-related events can be unpredictable, and patients may experience anxiety that impinges on their day-to-day functioning. When severe bleeding does occur, patients are necessarily hospitalized, which...